Skip to main content
. 2020 Sep 16;99(1):99–110. doi: 10.1111/cge.13843

FIGURE 4.

FIGURE 4

A, The impact of pre‐maturity on clinical outcomes, including death and developmental delay (DD). B, Variable outcomes with variable age of PLP administration. The earlier PLP was introduced as a therapy, the better the prognosis was reported. PLP, pyridoxal 5′‐phosphate